Indication
Abnormalities
3 clinical trials
4 products
1 drug
Clinical trial
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening: Reducing the Risk of Drug-Induced QT Interval Lengthening in WomenStatus: Completed, Estimated PCD: 2024-05-21
Product
ProgesteroneProduct
IbutilideClinical trial
A Double Blind, Placebo Controlled, Fixed-Flexible Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi SyndromeStatus: Recruiting, Estimated PCD: 2024-01-18
Product
GuanfacineClinical trial
Novel Approaches for Minimizing Drug-Induced QT Interval LengtheningStatus: Recruiting, Estimated PCD: 2024-12-31
Product
TestosteroneDrug
Varlilumab